Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 73, Issue 3-4, 2005, Pages 245-250

  Guilford, William J ^a   Parkinson, John F ^a  

^a BAYER AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 OXALIPOXIN A4; LIPOXIN A; UNCLASSIFIED DRUG;

COLITIS; CROHN DISEASE; DRUG EFFICACY; DRUG POTENCY; FATTY ACID OXIDATION; HUMAN; INFLAMMATION; NONHUMAN; ORGAN INJURY; PERITONITIS; PHARMACOPHORE; PRIORITY JOURNAL; REVIEW; SKIN EDEMA; SKIN INFLAMMATION;

ANIMALIA;

EID: 24344486889     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.05.012     Document Type: Article

References (29)

1. C.N. Serhan P. Hedqvist J.R. Kalden R. Müller-Peddinghaus D.R. Robinson Advances in Rheumatology and Inflammation 1991 Eular Basel 141 153
2. C.N. Serhan, and E. Oliw Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways J. Clin. Invest. 107 2001 1481 1489
3. W.J. Guilford, J.G. Bauman, and W. Skuballa Novel 3-oxa lipoxin A4 analogs with enhanced chemical and metabolic stability have anti-inflammatory activity in vivo J. Med. Chem. 47 2004 2157 2165
4. C.B. Clish, B.D. Levy, N. Chiang, H.H. Tai, and C.N. Serhan Oxidoreductases in lipoxin A4 metabolic inactivation: 15-oxaprostaglandin 13-reductase/leukotriene B4 12-hydroxydehydrogenase is a multifunctional eicosanoid oxidoreductase J. Biol. Chem. 33 2000 25372 25380
5. 4 Nat. Med. 8 2002 1018 1023
6. A.J. Schottelius, C. Giesen, and K. Asadullah An aspirin-triggered lipoxinA4 stable analog displays a unique topical anti-inflammatory profile J. Immunol. 168 2002 7064 7070
7. A.T. Gewirtz, L.S. Collier-Hyams, and A.N. Young Lipoxin A4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis J. Immunol. 168 2002 5260 5267
8. J. Aliberti, C.N. Serhan, and A. Sher Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection J. Exp. Med. 196 2002 1253 1262
9. C.B. Clish, J.A. O'Brien, K. Gronert, G.L. Stahl, N.A. Petasis, and C.N. Serhan Local and systemic delivery of a stable aspirin-triggered lipoxin prevents neutrophil recruitment in vivo Proc. Natl. Acad. Sci. USA 96 1999 8247 8252
10. C.K. Ellis, M.D. Smigel, J.A. Oates, O. Oelz, and B.J. Sweetman Metabolism of prostaglandin D2 in the monkey J. Biol. Chem. 254 1979 4152 4163
11. S. Sturzebecher, M. Haberey, and B. Muller Pharmacological profile of a novel carbacyclin derivative with high metabolic stability and oral activity in the rat Prostaglandins 31 1986 95 109
12. Y. Guindon, D. Delorme, C.K. Lau, and R. Zamboni Total synthesis of LTB4 and analogues J. Org. Chem. 53 1988 267 275
13. W. Skuballa, E. Schillinger, C. St. Stuerzebecher, and H. Vorbrueggen Synthesis of a new chemically and metabolically stable prostacyclin analogue with high and long-lasting oral activity J. Med. Chem. 29 1986 313 315
14. C.N. Serhan, M. Hamberg, and B. Samuelsson Trihydroxytetraenes: a novel series of compounds formed from arachidonic acid in human leukocytes Biochem. Biophys. Res. Commun. 118 1984 943 949
15. J. Adams, B.J. Fitzsimmons, and J. Rokach Synthesis of lipoxins: total synthesis of conjugated trihydroxy eicosatetraenoic acids Tetrahedron Lett. 25 1984 4713 4716
16. E.J. Corey, and W.G. Su Simple synthesis and assignment of stereochemistry of lipoxin A Tetrahedron Lett. 26 1985 281 284
17. K.C. Nicolaou, and S.E. Webber A general strategy for the total synthesis of the presumed lipoxin structures J. Chem. Soc. Chem. Commun. 1985 297 298
18. A.R. Rodriguez, and B.W. Spur Total synthesis of aspirin-triggered 15-epi-lipoxin A4 Tetrahedron Lett. 42 2001 6057 6060
19. E.D. Phillips, H.-F. Chang, C.R. Holmquist, and J.P. McCauley Synthesis of methyl (5R, 6R, 7E, 9E, 11Z, 13E, 15S)-16-(4-fluorophenoxy)-5,6,15- trihydroxy-7, 9, 11, 13-hexadecatetraenoate, an analogue of 15R-Lipoxin A4 Bioorg. Med. Chem. Lett. 2003 3223 3226
20. K.C. Nicolaou, C.A. Veale, S.E. Webber, and H. Katerinopoulos Stereocontrolled total synthesis of lipoxins A J. Am. Chem. Soc. 107 1985 7515 7518
21. T. Takano, C.B. Clish, K. Gronert, N. Petasis, and C.N. Serhan Neutrophil-mediated changes in vascular permeability are inhibited by topical application of aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 J. Clin. Invest. 101 1998 819 826
22. M. Hachicha, M. Pouliot, N.A. Petasis, and C.N. Serhan Lipoxin (LX)A4 and aspirin-triggered 15-epi-LXA4 inhibit tumor necrosis factor alpha-initiated neutrophil responses and trafficking: regulators of a cytokine-chemokine axis J. Exp. Med. 189 1999 1923 1930
23. C.N. Serhan, T. Takano, C.B. Clish, K. Gronert, and N. Petasis Aspirin-triggered 15-epi-lipoxin A4 and novel lipoxin B4 stable analogues inhibit neutrophil-mediated changes in vascular permeability Adv. Exp. Med. Biol. 469 1999 287 293
24. G. Bannenberg, R.-L. Moussignac, and K. Gronert Lipoxins and novel 15-epi-lipoxin analogs display potent anti-inflammatory actions after oral administration Br. J. Pharmacol. 143 2004 43 52
25. 4 receptor transgenic mice reveal novel protective roles for lipoxins and aspirin-triggered lipoxins in reperfusion J. Clin. Invest. 104 1999 309 316
26. 4 stable analogues are potent inhibitors of acute inflammation: evidence for anti-inflammatory receptors J. Exp. Med. 185 1997 1693 1704
27. C.N. Serhan, K.C. Nicolaou, S.E. Webber, C.A. Veale, S.E. Dahlén, T.J. Puustinen, and B. Samuelsson Lipoxin A. Stereochemistry and biosynthesis J. Biol. Chem. 261 1986 16340 16345
28. 4 in human neutrophils, Am. J. Physiol. 267 (1994) C1525-1534.
29. S. Fiorucci, J.L. Wallace, and A. Mencarelli A β-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction Proc. Natl. Acad. Sci. USA 101 2004 15736 15741